Maxcyte, Inc.
MXCT· Nasdaq
Released Mar 11, 2025, after the close
10-K filed Mar 11, 2025, 70 days after period end · 0001558370-25-002721
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | $22.47M | — | — | $7.51M |
| Net Income | -$10.60M |
Maxcyte, Inc. · CIK 1287098 · Engraved from SEC EDGAR
| -$5.28M |
| -$4.81M |
| -$4.87M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.